Access and reimbursement resources
If you want to learn more about access and reimbursement, we encourage you to view:
- EUPATI Training Portfolio Website: https://eupati.eu/training/
- Project HERCULES: projecthercules.org
- Realise Advocacy: Patient Advocacy Website: https://www.realiseadvocacy.com/
- The Association of the British Pharmaceutical Industry (ABPI) Code of Practice: https://www.abpi.org.uk/publications/
If you want to learn more about Health Technology Assessments (HTA), we encourage you to view the following HTA body websites:
- National Institute for Health and Care Excellence (NICE): https://www.nice.org.uk/
- Scottish Medicines Consortium (SMC): https://www.scottishmedicines.org.uk/
- Haute Autorité de Santé (HAS) in France: https://www.has-sante.fr/
- Gemeinsamer Bundesausschuss (GBA) in Germany: https://www.g-ba.de/
- Agenzia Italiana Del Farmaco (AIFA) in Italy: https://www.aifa.gov.it/en/web/guest/home
- NICE highly specialised technology (HST): https://www.nice.org.uk/process/pmg37/chapter/highly-specialised-technologies
- SMC Ultra Orphan Medicines Process: https://www.scottishmedicines.org.uk/how-we-decide/ultra-orphan-medicines-for-extremely-rare-conditions/
The resource shared here is an external source that Beacon had no involvement in creating. Whilst we believe this resource will be of benefit to our community, we cannot verify the accuracy, completeness, or reliability of the information provided in this resource. Sharing this resource does not imply endorsement, approval, or affiliation, nor have we received any compensation or benefit in return for sharing it. Please exercise your own judgment, and if necessary, consult with a qualified professional when relying on external information.